Geninus Inc. (389030.KQ) stock: key figures, P/E, revenue and dividend
Energy · Coal & Consumable Fuels · South Korea
Geninus Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 6.46 bn KRW | 10.48 bn KRW |
| Gross profit | 81.14 m KRW | 173.02 m KRW |
| Operating income | -12.29 bn KRW | -11.67 bn KRW |
| EBIT | -12.12 bn KRW | -16.74 bn KRW |
| Net income | -12.27 bn KRW | -17.37 bn KRW |
| Diluted EPS – continuing operations | -367.99 KRW | -520.90 KRW |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Geninus Inc.
GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia. It offers tarhet and biomarker discovery; AI digital pathology; single cell analysis; and spatial and in-situ transcriptomics services; and SPACEINSIGHT, a cutting-edge cloud based integrated analysis platform. It serves hospitals, pharmaceutical companies, and researchers. The company was founded in 2018 and is headquartered in Seoul, South Korea.
More stocks
- Sino Green Land Corp. (SGLA)
- Fair Value REIT-AG (FVI.F)
- Model Solution Co., Ltd. (417970.KQ)
- Luminescence Technology Corp. (6729.TWO)
- Cellid Co. Ltd (299660.KQ)
- Tongyang Pile Inc (228340.KQ)
- MANHATTAN BRIDGE CAPITAL, INC (LOAN)
- LiveOne, Inc. (LVO)
- YIHO International Co., Ltd. (7590.TWO)
- SITE Centers Corp. (SITC)
- Sunny Pharmtech Inc. (6676.TWO)
- Grove Collaborative Holdings, Inc. (GROV)
Not investment advice. All data without warranty, price as of 16.11.2026. Details in the risk notice.